Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929 Photoimmunotherapy in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to be Presented at ASCO 2024

Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929 Photoimmunotherapy in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to be Presented at ASCO 2024

Overall survival rate estimated at 24 months was 52.4% with generally tolerated safety profile Completed a…

Continue Reading
Qatar, WHO collaborate on revolutionary health information system for rehabilitation

Qatar, WHO collaborate on revolutionary health information system for rehabilitation

Doha, Qatar: In a landmark development that heralds a transformative era for rehabilitation healthcare, Hamad Medical…

Continue Reading
Health care ‘by the community, for the community’ with Professor Kelvin Kong

Health care ‘by the community, for the community’ with Professor Kelvin Kong

On the eve of the Indigenous Health Special Issue of the Medical Journal of Australia, in…

Continue Reading
Healthcare Facility Management: Sustainable Development and Digital Technology Application

Healthcare Facility Management: Sustainable Development and Digital Technology Application

Tuesday, 25/06/2024 On 21st June, FV Hospital organised a symposium on “Healthcare Facility Management” with the…

Continue Reading
Qatar, WHO collaborate on revolutionary health information system for rehabilitation

Qatar, WHO collaborate on revolutionary health information system for rehabilitation

In a landmark development that heralds a transformative era for rehabilitation healthcare, Hamad Medical Corporation (HMC)…

Continue Reading
Hearing Safety: Protecting Your Ears

Hearing Safety: Protecting Your Ears

It’s time to start a better conversation about hearing, say Geisinger otolaryngologist William Azeredo, MD, and…

Continue Reading